Epstein Files Search

EFTA00589949Set 9

2015-03-208p1,432w

Ava Lambert From: Sent: Friday, March 20, 2015 9:40 AM To: Ava Lambert Subject: Bellriinger service contract Attachments: Scan 150790001.pdf Good Morning Ava, Attached is a service contract ... Date: .3/‘//1 ---- ••••••••4 Approved by: ar0Z 2 b5^.--- • Date EFTA00589950 Ava Lambert From: Sent: Thursday, March 26, 2015 8:02 AM To: Ava Lambert Subject: Re: Invoices ... completed and this invoice is the balance due. Happy Spring! Andrew ----Original Message--- From: Ava Lambert < > To: crowfields10507 > Sent: Wed, Mar 25, 2015 9:38 am Subject: Invoices Good morning

https://www.justice.gov/epstein/files/DataSet%209/EFTA00589949.pdf

EFTA01299737Set 10

2015-09-2434p7,146w

MONKSHI 09/25/15 08.16.02 ENT MONKSHI 09/25/15 08.16.02 ULK MGNKSMI 09/25/15 08.16.02 APP SUFF EUR AVA V/D 9/25/USD DEBIT VS MMF/DBAB APPROVED /LOA RECD/CORP RES OK MONNSMI 09/25/15 08.15.50 LCK HGNJIAR ... HGNJIAR 09/24/15 17.14.44 LOM MGNPBUN 09/24/15 17.11.18 ULK WINPBUN 09/24/15 17.11.18 APP SUFF SUR AVA V/D 9/25/USD DEBIT VS MMF/DBAB APPROVED /LOA RECD/CORP RES OK NONEWAT 09/24/15 17.10.59 LCK NGNPBUN ... 09/24/25 27.04.08 ULK MGNPBUN 09/24/15 17.04.08 BID PENDING ADDITIONAL ACTIVITY. SUP? EUR AVA V/D 9/25/USD DEBIT VS AMF/DBAB APPROVED /LOA RECD/CORP RES OK HOWPWAI 09/24/15 17.02.10 LCK MGNPBUN 09/24/15

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01299737.pdf

EFTA01299771Set 10

2015-09-2434p7,189w

MONKSHI 09/25/15 08.16.02 SNT MONKSMI 09/25/15 08.16.02 ULK HGNKSMI 09/25/15 08.16.02 APP SUP? EUR AVA V/D 9/25/USD DEBIT VS NNF/DBAB APPROVED /LOA RECD/CORP RES OK MOINKSMI 09/25/15 08.15.50 LCK IIGHTIAR ... HGNJIAR 09/24/15 17.14.44 LOS MGNPBUN 09/24/15 17.11.18 ULK 102NPBUN 09/24/15 17.11.18 APP SUFF SUR AVA V/D 9/25/USD DEBIT VS MMF/DBAB APPROVED /LOA RECD/CORP RES OK MGNPBUN 09/24/15 17.10.59 LCK HOMPWRI ... 09/24/15 17.04.08 ULK MGNPBUN 09/24/15 17.04.08 HID PENDING ADDITIONAL ACTIVITY. SUFF EUR AVA V/D 9/25/USD DEBIT VS 101E/DRAB APPROVED /LOA RECD/CORP RES OK MONPRIMI 09/24/15 17.02.10 LCK MGNPBUN 09/24/15

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01299771.pdf

EFTA02080221Set 10

2015-04-162p204w

From: Ava Lambert Sent Thur 4/16/2015 6:55:59 PM Subject: RE: Tentative Date for the Trustees Meeting No problem. From: Sent: Thursday, April ... Ava Lambert Subject: Re: Tentative Date for the Trustees Meeting OK, I let him know about it...but I am pretty sure he has to be in PB this ... meeting been confirmed for May 5th? On Apr 16, 2015, at 2:53 PM, Ava Lambert < wrote: FI I am not sure but I think they wanted to keep

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02080221.pdf

EFTA01412850Set 10

2015-08-144p585w

Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program BFW 08/13 20:24 *AVALANCHE WON'T START A PHASE 2B TRIAL OF AVA ... 08/13 20:24 *AVALANCHE WONT START A PHASE 2B TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT STARTA PHASE 2B TRIAL OF AVA ... after further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01412850.pdf

EFTA01368503Set 10

2015-08-131p342w

Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program BFW 08/13 20:24 "AVALANCHE WON'T START A PHASE 2B TRIAL OF AVA ... 08/13 20:24 *AVALANCHE WONT START A PHASE 26 TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT STARTA PHASE 2B TRIAL OF AVA ... after further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01368503.pdf

EFTA00848760Set 9

2015-08-143p650w

Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program BFW 08/13 20:24 *AVALANCHE WON'T START A PHASE 26 TRIAL OF AVA ... 08/13 20:24 *AVALANCHE WONT START A PHASE 26 TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT STARTA PHASE 2B TRIAL OF AVA ... after further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded

https://www.justice.gov/epstein/files/DataSet%209/EFTA00848760.pdf

EFTA01206023Set 9

2015-08-143p736w

Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program BFW 08/13 20:24 *AVALANCHE WON'T START A PHASE 26 TRIAL OF AVA ... 08/13 20:24 *AVALANCHE WONT START A PHASE 26 TRIAL OF AVA-101 FOR WET AMD BN 08/13 20:24 *AVALANCHE WONT STARTA PHASE 2B TRIAL OF AVA ... after further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded

https://www.justice.gov/epstein/files/DataSet%209/EFTA01206023.pdf

EFTA00626670Set 9

2016-12-1856p13,307w

100F0o..70 I ).E.I-00t1. M_LI.Wa+.080 ' 0{!G00AA*s0 L.I p.POW Ern.]vr!AvA****!!....- ®D{.011.0.hb< 0.00 tAZA%L..I 0: ' W100 PAhi .m0]v4Av ... 04418o oN0w4e oBOOp7t*oA-400.2*o ^3.a4/141.[of-4OO. ..o 40. BKOi•AvA ARP* **4•4WAN 6Sko < >rAXA{ °AZ.Ay. I 0.51Aogg;ACAqzARA; $9BOAAe-r}080A.A...... A AAAAAY-SzAA ... 0a.000=00 440 = w*A—Jv r*V!!zA} ***TT*+0s******=+ r*Ava***Sti ABAz4GdiwIR>QAE****x**c;*/* ;BO-LL0s*tAbQ}A/ PAcE0.—V I O:!CRON

https://www.justice.gov/epstein/files/DataSet%209/EFTA00626670.pdf

EFTA00689626Set 9

2015-06-163p994w

fell as much as 32 percent to $26.40 in late trading. The study assessed AVA-101's safety for patients with the disease, called wet age-related macular degeneration ... study wasn't designed to show statistically significant differences, the group treated with AVA-101 got an average of two extra injections of Roche Holding AG's Lucentis, compared with ... with 9.1 percent of patients in the control group of 11 patients. If approved, AVA-101 would be the first gene therapy for the condition and could replace current options

https://www.justice.gov/epstein/files/DataSet%209/EFTA00689626.pdf

EFTA01368453Set 10

1p495w

fell as much as 32 percent to $26.40 in late trading. The study assessed AVA-101's safety for patients with the disease, called wet age-related macular degeneration ... study wasn't designed to show statistically significant differences, the group treated with AVA-101 got an average of two extra injections of Roche Holding AG's Lucentis, compared with ... with 9.1 percent of patients in the control group of 11 patients. If approved, AVA-101 would be the first gene therapy for the condition and could replace current options

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01368453.pdf

EFTA02088808Set 10

2014-12-032p85w

From: Ava Lambert Sent: Wed 12/3/2014 7:49:09 PM Subject: RE: Package Thank you! From: Sent: Wednesday, December 03, 2014 2:47 PM To: Ava Lambert Subject: Re: Package ... package received! On Dec 3, 2014, at 1:07 PM, Ava Lambert < wrote: Hi- I hope you had a wonderful Thanksgiving. Rich Joslin asked me to messenger a package over ... Epstein. Best regards, Ava AVA LAMBERT OFFICE ADMINISTRATOR ELYSIUM MANAGEMENT LLC 445 PARK AVENUE, SUITE 1401 EFTA_R1_00882495 EFTA02088808 New YoRK,NY 10022 EFTA_R1_00882496 EFTA02088809

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02088808.pdf

EFTA00639496Set 9

2014-12-1521p4,426w

A.Als04444j***#40* •.0)f-**BIA•Ai AAA AO4 A%Ad* 4:1>AvA*7•&L, LAgA*014*** {•\ow/ {bi,, AAA! fr.r.17*k., A.*? rnAg ... ASAIM—A!ZAA@A5i 00...00/x(AOMAic6BIAA EI~I-AE*4>A'. di*Ou'AvA. v...D.A\A-Eio...b.+A..00.4~EAYARAvti...bdziAp ... zAGAkc !!..o00 Au-xv4444Ag@40-4-444/ EFTA00639509 0•4*]AvA>T4ArrA.A+cAAA b op*:A+44.44a4r8B400>0uw^AdAMA* **At) AVAttz.ONbAAvi-AWAO:TiA-AAw0401-10kAwAdAVA40Atv.AAEAAAAnA'r*Ay A- T& E9ADAA

https://www.justice.gov/epstein/files/DataSet%209/EFTA00639496.pdf

EFTA00359010Set 9

2014-11-113p369w

Clapp <1 To: Richard Joslin , Eileen Alexanderson Richard , lawrence delson Heather Gray Cc: Ava Lambert <I Subject: RE: team meeting Date ... Clapp; Eileen Alexanderson; Richard lawrence delson; Heather Gray Cc: Ava Lambert; Subject: RE: team meeting EFTA00359010 To the extent the art partnership will be a topic of discussion, JEE would ... Eileen Alexanderson; Richard D'Agostino; lawrence delson; Heather Gray; Richard Joslin Cc: Ava Lambert Subject: RE: team meeting I think that is a good idea. I am available. Thanks

https://www.justice.gov/epstein/files/DataSet%209/EFTA00359010.pdf

EFTA00854210Set 9

2015-06-164p1,260w

placebo arm was sub-optimal for maintaining their stable VA while the AVA-101 treated arm was able to maintain (and even improve ) the baseline levels of visual acuity. -More ... AVA-101 treated subjects improved or maintained stable vision (>-5 letters) with a low number (≤2) of rescue treatments. Specifically, 23.8 percent (treated) vs. 9.1 percent (control) maintained stable vision ... with ≤1 rescue injections, and a significant number of AVA-101 treated subjects (42.9 percent) improved or maintained stable vision with ≤2 rescue injections compared with subjects in the control

https://www.justice.gov/epstein/files/DataSet%209/EFTA00854210.pdf

EFTA00771165Set 9

2009-10-078p2,964w

GENERAL RELEASE (the "Agreement") is entered into as of October , 2009, by and between Ava a.k.a. Maximilia Cordero ("Plaintiff") and Jacqueline Mari ("Mari"), on the one hand, and Jeffrey Epstein ... with respect to that certain action commenced on or about October 22, 2007, captioned Ava a.k.a. Maximilia Corder() v. Jeffrey Epstein, Victoria's Secret Stores Brand Management Inc. a.k.a. Victoria ... AGREEMENT AND GENERAL RELEASE as of the date first written above. Dated: October 2009 AVA A.K.A. MAXIMILIA CORDERO Ava a.k.a. Maximilia Cordero Subscribed and sworn to before me this

https://www.justice.gov/epstein/files/DataSet%209/EFTA00771165.pdf

EFTA00731219Set 9

2009-10-078p2,964w

GENERAL RELEASE (the "Agreement") is entered into as of October , 2009, by and between Ava a.k.a. Maximilia Cordero ("Plaintiff") and Jacqueline Mari ("Mari"), on the one hand, and Jeffrey Epstein ... with respect to that certain action commenced on or about October 22, 2007, captioned Ava a.k.a. Maximilia Corder() v. Jeffrey Epstein, Victoria's Secret Stores Brand Management Inc. a.k.a. Victoria ... AGREEMENT AND GENERAL RELEASE as of the date first written above. Dated: October 2009 AVA A.K.A. MAXIMILIA CORDERO Ava a.k.a. Maximilia Cordero Subscribed and sworn to before me this

https://www.justice.gov/epstein/files/DataSet%209/EFTA00731219.pdf

EFTA01256014Set 9

2014-12-1724p4,905w

Currency wire got settled. 12/16/14 11.34.30 PPR 12/16/14 11.34.30 ULX 12/16/14 11.34.30 APP FDS AVA VD 12-17/W9/SLOA/DBAB 12/16/14 11.33.56 LCX 12/16/14 10.49.23 ULK 12/16/14 ... DATE TIME STATUS COMMENTS 12/17/14 08.43.31 SET 12/17/14 08.43.31 ULK 12/17/14 08.43.31 APP PDS AVA VD 12-17/89/SLOA/DBAB/FDS TO °COVER PEE 12/17/14 08.41.24 LCX 12/17/14 08.37.48 ULK 12/17/14 ... AVAIL - W811 12/17/14 08.24.23 LCK 12/17/14 08.21.36 ULK 12/17/14 08.21.36 APP FDS AVA VD 12-17/W8-11/LOA RECD/DBAB/MULTI/FDS TO COVER FEE 12/17/14 08.20.44 LCK SDNY_GM_00065941 CONFIDENTIAL - PURSUANT

https://www.justice.gov/epstein/files/DataSet%209/EFTA01256014.pdf

EFTA02278571Set 11

2019-02-01141p30,813w

first, after that you will call Air France about upgrade, if it is still ava them on the line. Regards, Natalia (Natasha) Molotkova Centurion Relationship Mana er Hours: Mon through ... first, after that you will call Air France about upgrade, if it is still ava them on the line. Regards, Natalia (Natasha) Molotkova Centurion Relationship Manager Hours: Mon through Friday ... first, after that you will call Air France about upgrade, if it is still ava them on the line. Regards, Natalia (Natasha) Molotkova Centurion Relationship Manager Hours: Mon through Friday

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02278571.pdf

EFTA01696301Set 10

2006-10-0298p21,916w

Anti Lock Brakes: 4 wheel shop:lard Air Con/Atoning: Standard Daytime Runreng Lights: Not ava table Pave' Steering: Standard Powe- Bake;: Standard Paver WindcfAs. Standard Security System. None Roof: None

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01696301.pdf